GSH2™ - Self-screening heart failure feature (in development)

The GSH2™ app will provide an alerting feature for early intervention to heart failure patients. It uses individualized machine learning to predict acute decompensated heart failure (ADHF) by alerting the patients to seek earlier medical care and alerting your doctors that the patient is indicated at risk of ADHF.

*Planned clinical trial will take place in Q4 2024 for 18 months
  • GSH2™ is an upcoming personalized self-screening app for heart failure patients. The app assists you in medication compliance and helps keep you outside of the ward by alerting you 7-10 days of potential worsening heart failure status that could lead to hospital admission​